MiniMed Short Interest Surged to 99% of Float
Arbitrageurs have aggressively shorted MiniMed stock to profit from a share swap offer tied to Medtronic.
Updated on Oct. 9, 2026 in Public Companies
Live Poll
Do you trust that complex corporate stock swap deals are fair for the average investor?
Short interest in MiniMed reached 99% of its 28.5 million share float as investors rushed to participate in a Medtronic share swap. The surge follows an arbitrage play seeking to profit from the price premium between the two entities.
Why it matters
The extreme short position highlights the risks and mechanics of capture-style arbitrage, where traders borrow nearly all available shares to capitalize on specific conversion ratios. This activity can cause significant price volatility for small-cap equities caught in such financial instruments.
Short interest surged to 99% of the 28.5 million share float, up from 47.6% on September 15 and 77% just one week prior to October 7. Medtronic has offered 225.3 million shares of MiniMed in a swap with a 4.5939 exchange cap.
The players
Medtronic
A global medical technology company that maintains a large stake in MiniMed following a 2026 spin-off.
MiniMed
A public company operating in the medical device sector that has become the target of heavy arbitrage-driven short selling.
The details
Arbitrageurs bought Medtronic stock to tender in the share swap while simultaneously shorting MiniMed shares to lock in price differentials. With 99% of the float borrowed and sold short, almost no stock remained available for other market participants. This heavy borrowing activity contributed to a 12% decline in MiniMed's stock price on October 2.
Timeline
March 2026: Medtronic spun off MiniMed in an IPO.
September 15, 2026: MiniMed short interest was 47.6%.
October 2, 2026: MiniMed stock price declined by 12%.
October 7, 2026: MiniMed short interest reached 99% of its float.
October 9, 2026: The Medtronic share swap offer expires at midnight.
Market Landscape
This intense shorting cycle represents the final stages of the 2026 Medtronic spinoff of MiniMed. It follows a common pattern in corporate spin-offs where price premiums between parent and subsidiary entities attract institutional arbitrage capital.
Operators holding equity in companies undergoing spinoffs or swap offers should monitor liquidity, as extreme short interest can trigger rapid price fluctuations. If you are involved in corporate finance, review borrowing costs and share availability when restructuring processes reach the final tender stage.
The takeaway
The MiniMed event serves as a reminder that arbitrage strategies can temporarily corner the supply of a company's available float. Businesses should track short interest metrics when managing equity relations to anticipate potential volatility during capital-intensive transition periods.
What happens next
The Medtronic share swap offer is set to expire at midnight this Friday, with the conversion expected to execute within the following few trading days.
Further reading
For broader trends in equity restructuring, see Public Companies.
Source note: This article includes information reported by Protos.
Live Poll
Do you trust that complex corporate stock swap deals are fair for the average investor?
